AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31317534 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized antibiotic stewardship quality improvement program
Number of subjects: 27
Study 31378975 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive periodontal therapy (SPT) consisting of oral prophylaxis with oral hygiene instructions
Number of subjects: 62
Study 31378975 — intervention group
Group type: COMPARATOR
Intervention: Supportive periodontal therapy (SPT) combined with subgingival instrumentation
Number of subjects: 62
Study 31378975 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive periodontal therapy (SPT)
Number of subjects: 62
Study 27862178 — intervention group
Group type: EXPERIMENTAL
Intervention: rHSA/IFNα2a 600 μg
Number of subjects: 32
Study 27862178 — intervention group
Group type: EXPERIMENTAL
Intervention: rHSA/IFNα2a 750 μg
Number of subjects: 32
Study 27862178 — intervention group
Group type: EXPERIMENTAL
Intervention: rHSA/IFNα2a 900 μg
Number of subjects: 32
Study 27862178 — intervention group
Group type: COMPARATOR
Intervention: PEG-IFNα2a 180 μg
Number of subjects: 32
Study 25249142 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm-up (10 min practice session in simulation lab)
Number of subjects: 40
Study 22914267 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir gel
Number of subjects: 445
Study 22914267 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 445
Study 21564315 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingent electrical stimulation (CES)
Number of subjects: 14
Study 21564315 — intervention group
Group type: COMPARATOR
Intervention: No CES (Control)
Number of subjects: 14
Study 19451183 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing well-fitting masks
Number of subjects: 80
Study 19451183 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital hygiene procedures (control)
Number of subjects: 80
Study 16701184 — intervention group
Group type: EXPERIMENTAL
Intervention: mepivacaine 2%
Number of subjects: 47
Study 16701184 — intervention group
Group type: COMPARATOR
Intervention: lidocaine 2%
Number of subjects: 47
Study 12619262 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzocaine patch (12 mg)
Number of subjects: 60
Study 12619262 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 60
Study 11218544 — intervention group
Group type: EXPERIMENTAL
Intervention: male and female condom plus N-9 products (vaginal suppositories, film, gel)
Number of subjects: 41
Study 11218544 — intervention group
Group type: COMPARATOR
Intervention: male and female condom
Number of subjects: 41
Study 8808885 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 Hz stimulation at pulses 1 msec
Number of subjects: 33
Study 8808885 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 Hz stimulation at pulses 1 msec
Number of subjects: 33
Study 8808885 — intervention group
Group type: EXPERIMENTAL
Intervention: 95 Hz stimulation at pulses 0.5 msec
Number of subjects: 33
Study 1430286 — intervention group
Group type: EXPERIMENTAL
Intervention: Gingivectomy (GV)
Number of subjects: 14
Study 1430286 — intervention group
Group type: COMPARATOR
Intervention: Modified Widman flap (MWF)
Number of subjects: 14
Study 3917631 — intervention group
Group type: EXPERIMENTAL
Intervention: Eucapnic voluntary hyperventilation (EVH) using a simplified dry gas mixture
Number of subjects: 10
Study 3917631 — intervention group
Group type: COMPARATOR
Intervention: Standard exercise protocol ventilating ad libitum from dry air at room temperature
Number of subjects: 10
Study 3561604 — intervention group
Group type: EXPERIMENTAL
Intervention: Cis-dichlorodiammineplatinum (DDP) 100 mg/m2 infused for 4 h on 5 consecutive days
Number of subjects: 105
Study 3561604 — intervention group
Group type: EXPERIMENTAL
Intervention: Cis-dichlorodiammineplatinum (DDP) 20 mg/m2 infused for 1 h on 5 consecutive days
Number of subjects: 105
Study 3561604 — intervention group
Group type: COMPARATOR
Intervention: Both administration schedules of DDP
Number of subjects: 105
Study 29271855 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine Spray (LS) - 40 mg of 10% lidocaine spray applied thoroughly to the cervix
Number of subjects: 132
Study 29271855 — intervention group
Group type: COMPARATOR
Intervention: Paracervical Block (PB) - 10 mL of 2% lidocaine with 1:100,000 epinephrine
Number of subjects: 132
Study 29271855 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine Spray (LS)
Number of subjects: 132
Study 28025154 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS‐FNA with 4 passes
Number of subjects: 239
Study 28025154 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS‐FNA with 6 passes
Number of subjects: 239
Study 28025154 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS‐FNA with 4 passes in masses >2 cm
Number of subjects: 239
Study 28025154 — intervention group
Group type: COMPARATOR
Intervention: EUS‐FNA with more than 4 passes
Number of subjects: 239
Study 25794213 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed radiofrequency (PRF) for each nerve root, 2 cycles
Number of subjects: 21
Study 25794213 — intervention group
Group type: COMPARATOR
Intervention: Sham PRF (control group)
Number of subjects: 21
Study 23758955 — intervention group
Group type: EXPERIMENTAL
Intervention: In-plane multiangle needle guide
Number of subjects: 16
Study 23758955 — intervention group
Group type: COMPARATOR
Intervention: No needle guide (Control)
Number of subjects: 16
Study 20354444 — intervention group
Group type: EXPERIMENTAL
Intervention: Community popular opinion leader intervention
Number of subjects: 0
Study 20354444 — intervention group
Group type: COMPARATOR
Intervention: AIDS education comparison
Number of subjects: 0
Study 18494842 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency management (CM)
Number of subjects: 165
Study 18494842 — intervention group
Group type: COMPARATOR
Intervention: Standard methadone treatment
Number of subjects: 165
Study 16796897 — intervention group
Group type: EXPERIMENTAL
Intervention: T1G3 group
Number of subjects: 72
Study 14604707 — intervention group
Group type: EXPERIMENTAL
Intervention: Bitoric ablation (Group 1)
Number of subjects: 15
Study 14604707 — intervention group
Group type: COMPARATOR
Intervention: Monotoric ablation (Group 2)
Number of subjects: 15
Study 11036470 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose-intense M-VAC with G-CSF support
Number of subjects: 162
Study 11036470 — intervention group
Group type: COMPARATOR
Intervention: Conventional-dose M-VAC
Number of subjects: 162
Study 8977854 — intervention group
Group type: EXPERIMENTAL
Intervention: Antral washouts followed by antibiotics and topical nasal steroids
Number of subjects: 114
Study 8977854 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics and topical nasal steroids alone
Number of subjects: 114
Study 1296491 — intervention group
Group type: EXPERIMENTAL
Intervention: Ioversol 300
Number of subjects: 0
Study 1296491 — intervention group
Group type: COMPARATOR
Intervention: Iopamidol 300
Number of subjects: 0
Study 6242801 — intervention group
Group type: EXPERIMENTAL
Intervention: Human insulin zinc suspension crystalline (recombinant DNA)
Number of subjects: 10
Study 6242801 — intervention group
Group type: COMPARATOR
Intervention: Highly purified porcine insulin zinc suspension (mixed)
Number of subjects: 10
Study 30797836 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy breakfast composition
Number of subjects: 460
Study 30797836 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher education level, being a woman, reporting to be fit
Number of subjects: 460
Study 30797836 — intervention group
Group type: EXPERIMENTAL
Intervention: Preferences for low-fat, familiar or convenient foods
Number of subjects: 460
Study 29990948 — intervention group
Group type: EXPERIMENTAL
Intervention: Outdoor traffic noise (modelled using the Nordic prediction model)
Number of subjects: 7321
Study 29990948 — intervention group
Group type: EXPERIMENTAL
Intervention: Modelled noise levels higher than 60 dB
Number of subjects: 7321
Study 29990948 — intervention group
Group type: EXPERIMENTAL
Intervention: Modelled noise for respondents whose bedroom windows faced the street
Number of subjects: 7321
Study 29990948 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise sensitivity
Number of subjects: 7321
Study 27618593 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 1075
Study 27618593 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (SA)
Number of subjects: 1075
Study 24444257 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Number of subjects: 51
Study 24444257 — intervention group
Group type: COMPARATOR
Intervention: Clindamycin
Number of subjects: 51
Study 22310411 — intervention group
Group type: EXPERIMENTAL
Intervention: Plate fixation for open-door laminoplasty
Number of subjects: 49
Study 22310411 — intervention group
Group type: COMPARATOR
Intervention: Suture group (control) for open-door laminoplasty
Number of subjects: 49
Study 20210615 — intervention group
Group type: COMPARATOR
Intervention: Control clothing (CON)
Number of subjects: 10
Study 20210615 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial uniform (PART)
Number of subjects: 10
Study 20210615 — intervention group
Group type: EXPERIMENTAL
Intervention: Full uniform (FULL)
Number of subjects: 10
Study 18329126 — intervention group
Group type: COMPARATOR
Intervention: Lamivudine 100 mg daily plus placebo (monotherapy)
Number of subjects: 115
Study 18329126 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamivudine 100 mg plus adefovir dipoxil 10 mg daily (combination therapy)
Number of subjects: 115
Study 15949731 — intervention group
Group type: EXPERIMENTAL
Intervention: T-cell-adapted ATG induction therapy (Sangstat) 1.5 mg/kg for 3.9 ± 1.6 days
Number of subjects: 62
Study 15949731 — intervention group
Group type: COMPARATOR
Intervention: Control group with full-dose ATG regimen (Merieux) for 8 days
Number of subjects: 62
Study 15949731 — intervention group
Group type: EXPERIMENTAL
Intervention: Study group
Number of subjects: 62
Study 15949731 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 62
Study 15949731 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 62
Study 12500934 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy intervention (TG)
Number of subjects: 65
Study 12500934 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 65
Study 9660555 — intervention group
Group type: COMPARATOR
Intervention: NAA/Cr ratio in right medial temporal lobe
Number of subjects: 21
Study 9660555 — intervention group
Group type: COMPARATOR
Intervention: Choline/Cr ratio in left medial temporal lobe
Number of subjects: 21
Study 7807104 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented total hip arthroplasty
Number of subjects: 60
Study 7807104 — intervention group
Group type: COMPARATOR
Intervention: Noncemented total hip arthroplasty
Number of subjects: 60
Study 2668140 — intervention group
Group type: EXPERIMENTAL
Intervention: Ruscus extract
Number of subjects: 20
Study 2668140 — intervention group
Group type: EXPERIMENTAL
Intervention: Hesperidine methyl chalcone (HMC)
Number of subjects: 20
Study 2668140 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Ruscus extract and HMC
Number of subjects: 20
Study 2668140 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 865369 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferro-Grad Folic
Number of subjects: 103
Study 865369 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferro-Gradumet
Number of subjects: 103
Study 865369 — intervention group
Group type: COMPARATOR
Intervention: FGF
Number of subjects: 103
Study 865369 — intervention group
Group type: COMPARATOR
Intervention: Slow-Fe
Number of subjects: 103
Study 865369 — intervention group
Group type: COMPARATOR
Intervention: Lower dose iron group
Number of subjects: 103
Study 31104040 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month multicomponent health promotion intervention including a smoking cessation and counseling program.
Number of subjects: 222
Study 31104040 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) with no specific intervention mentioned.
Number of subjects: 222
Study 29677565 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm ergometer aerobic training combined with resistance training
Number of subjects: 78
Study 29677565 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill aerobic training combined with resistance training
Number of subjects: 78
Study 29677565 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycle ergometer aerobic training combined with resistance training
Number of subjects: 78
Study 27012435 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal buprenorphine (2, 8 & 16 mg)
Number of subjects: 11
Study 27012435 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal buprenorphine/naloxone (2/0.5, 8/2 & 16/4 mg)
Number of subjects: 11
Study 27012435 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 24551053 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiving help
Number of subjects: 0
Study 24551053 — intervention group
Group type: EXPERIMENTAL
Intervention: Observing help
Number of subjects: 0
Study 22815837 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 g type 2 resistant starch
Number of subjects: 12
Study 22815837 — intervention group
Group type: COMPARATOR
Intervention: Energy and carbohydrate-matched placebo
Number of subjects: 12
Study 19158197 — intervention group
Group type: EXPERIMENTAL
Intervention: GH treatment (1.0 mg/m².d for infants and prepubertal children; 1.0 or 1.5 mg/m².d for pubertal children)
Number of subjects: 91
Study 19158197 — intervention group
Group type: COMPARATOR
Intervention: Control group (no GH treatment)
Number of subjects: 91
Study 17484756 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil (10 mg/day)
Number of subjects: 23
Study 17484756 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 15098800 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymorphone extended release (ER) 5 mg
Number of subjects: 24
Study 15098800 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymorphone extended release (ER) 10 mg
Number of subjects: 24
Study 15098800 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymorphone extended release (ER) 20 mg
Number of subjects: 24
Study 15098800 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymorphone extended release (ER) 40 mg
Number of subjects: 24
Study 15098800 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymorphone extended release (ER) 5 mg every 12 hrs
Number of subjects: 24
Study 15098800 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymorphone extended release (ER) 10 mg every 12 hrs
Number of subjects: 24
Study 15098800 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymorphone extended release (ER) 20 mg every 12 hrs
Number of subjects: 24
Study 15098800 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymorphone extended release (ER) 40 mg every 12 hrs
Number of subjects: 24
Study 15098800 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolites (6-hydroxyoxymorphone and oxymorphone-3-glucuronide)
Number of subjects: 24
Study 11823730 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring of glucose levels
Number of subjects: 278
Study 11823730 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood glucose monitoring
Number of subjects: 278
Study 11823730 — intervention group
Group type: COMPARATOR
Intervention: Urine glucose monitoring
Number of subjects: 278
Study 9395005 — intervention group
Group type: EXPERIMENTAL
Intervention: six month preseasonal SLIT with Lolium perenne extract (n = 35)
Number of subjects: 54
Study 9395005 — intervention group
Group type: EXPERIMENTAL
Intervention: nine-month pre-coseasonal SLIT (n = 30 from treated group)
Number of subjects: 54
Study 9395005 — intervention group
Group type: EXPERIMENTAL
Intervention: forty-two treated patients
Number of subjects: 54
Study 9395005 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 19)
Number of subjects: 54
Study 8179173 — intervention group
Group type: EXPERIMENTAL
Intervention: General anaesthesia (GA) with 0.1‐0.15 mg/kg midazolam and 10 micrograms/kg fentanyl prior to skin incision; maintenance included 65% nitric oxide in oxygen and 0.1 mg increments of fentanyl as required.
Number of subjects: 40
Study 8179173 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined technique of dose‐reduced general anaesthesia and supplementary continuous thoracic epidural anaesthesia (bupivacaine 0.25%, sensory blockade T4 to L1‐3).
Number of subjects: 40
Study 8179173 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (no ibuprofen).
Number of subjects: 40
Study 8179173 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (400 mg i.v.) administered 15 min before induction of anaesthesia.
Number of subjects: 40
Study 3035164 — intervention group
Group type: COMPARATOR
Intervention: Conventional oral hygiene procedures
Number of subjects: 347
Study 3035164 — intervention group
Group type: COMPARATOR
Intervention: Sodium bicarbonate, hydrogen peroxide, and sodium chloride (S/P) oral hygiene
Number of subjects: 347
Study 3035164 — intervention group
Group type: COMPARATOR
Intervention: Conventional oral hygiene procedures plus phase‐contrast demonstration
Number of subjects: 347
Study 3035164 — intervention group
Group type: COMPARATOR
Intervention: S/P oral hygiene plus phase‐contrast demonstration
Number of subjects: 347
Study 28959911 — intervention group
Group type: EXPERIMENTAL
Intervention: SIT (sprint interval training)
Number of subjects: 21
Study 28959911 — intervention group
Group type: COMPARATOR
Intervention: MICT (moderate intensity continuous training)
Number of subjects: 21
Study 28959911 — intervention group
Group type: EXPERIMENTAL
Intervention: Both MICT and SIT
Number of subjects: 21
Study 28664579 — intervention group
Group type: COMPARATOR
Intervention: Heparin bridging
Number of subjects: 110
Study 28664579 — intervention group
Group type: EXPERIMENTAL
Intervention: Uninterrupted warfarin
Number of subjects: 110
Study 28664579 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 110
Study 25661668 — intervention group
Group type: EXPERIMENTAL
Intervention: Air Temperature Control (ATC)
Number of subjects: 38
Study 25661668 — intervention group
Group type: COMPARATOR
Intervention: Skin Servocontrol (SSC)
Number of subjects: 38
Study 23957018 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical removal of third molars
Number of subjects: 3
Study 20861643 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific IgE to peanut extract and recombinant Ara h 2 and Ara h 6
Number of subjects: 237
Study 20861643 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant Ara h 2
Number of subjects: 237
Study 19088953 — intervention group
Group type: EXPERIMENTAL
Intervention: External bleaching with Illumine office (30% hydrogen peroxide) for 60 minutes followed by home bleaching with Illumine home (15% carbamide peroxide) for 2 weeks with daily bleaching time of 1 hour
Number of subjects: 18
Study 19088953 — intervention group
Group type: COMPARATOR
Intervention: Control group (no bleaching treatment)
Number of subjects: 18
Study 19088953 — intervention group
Group type: EXPERIMENTAL
Intervention: External bleaching with Illumine office (30% hydrogen peroxide) followed by home bleaching
Number of subjects: 18
Study 16532017 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased bone marrow iron stores (BMIS) prior to ASCT
Number of subjects: 367
Study 16532017 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 367
Study 16532017 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of severe neutropenia post-ASCT (<100 ANC/microl)
Number of subjects: 367
Study 16532017 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased BMIS (multivariate analysis)
Number of subjects: 367
Study 16532017 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking (multivariate analysis)
Number of subjects: 367
Study 12649049 — intervention group
Group type: COMPARATOR
Intervention: Basic Internet-based, information-focused intervention
Number of subjects: 320
Study 12649049 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored self-management training
Number of subjects: 320
Study 12649049 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support components
Number of subjects: 320
Study 10749297 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous calcitriol administered two times weekly (G-2/w)
Number of subjects: 22
Study 10749297 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous calcitriol administered three times weekly (G-3/w)
Number of subjects: 22
Study 8767977 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral amtolmetineguacyl 600 mg/day
Number of subjects: 24
Study 8767977 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 7840914 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine
Number of subjects: 467
Study 7840914 — intervention group
Group type: COMPARATOR
Intervention: Zalcitabine
Number of subjects: 467
Study 3358822 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral thiamin supplementation (250 mg daily for 5 days)
Number of subjects: 25
Study 3358822 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral thiamin supplementation (250 mg daily for 5 days)
Number of subjects: 25
Study 3358822 — intervention group
Group type: COMPARATOR
Intervention: Parenteral thiamin supplementation (250 mg within 24 hr)
Number of subjects: 25
Study 29490101 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega‐3‐6‐9 Junior (Nordic Naturals, Inc.) treatment (338 mg eicosapentaenoic acid, 225 mg DHA, and 83 mg GLA)
Number of subjects: 31
Study 29490101 — intervention group
Group type: COMPARATOR
Intervention: Canola oil (124 mg palmitic acid, 39 mg stearic acid, 513 mg linoleic acid, 225 mg α‐linolenic acid, and 1346 mg oleic acid)
Number of subjects: 31
Study 28628702 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives (coupons redeemable for $125 cash-equivalent gift cards upon linkage to care)
Number of subjects: 1061
Study 28628702 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives ($70 gift cards quarterly for viral suppression)
Number of subjects: 1061
Study 24357856 — intervention group
Group type: EXPERIMENTAL
Intervention: Palifermin
Number of subjects: 20
Study 22156973 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined oral contraceptives (COCs)
Number of subjects: 5567
Study 22156973 — intervention group
Group type: EXPERIMENTAL
Intervention: Depo-medroxyprogesterone acetate (DMPA)
Number of subjects: 5567
Study 22156973 — intervention group
Group type: EXPERIMENTAL
Intervention: Norethisterone enanthate (Net-En)
Number of subjects: 5567